Campo, GianlucaPavasini, RitaMorciano, GiampaoloLincoff, Michael A.Gibson, Michael C.Kitakaze, MasafumiLonborg, JacobAhluwalia, AmritaIshii, HidekiFrenneaux, MichaelOvize, MichelGalvani, MarcelloAtar, DanIbanez, BorjaCerisano, GiampaoloBiscaglia, SimoneNeil, Brandon J.Asakura, MasanoriEngstrom, ThomasJones, Daniel A.Dawson, DanaFerrari, RobertoPinton, PaoloOttani, Filippo2017-09-072017-09-072017-10Campo, G, Pavasini, R, Morciano, G, Lincoff, M A, Gibson, M C, Kitakaze, M, Lonborg, J, Ahluwalia, A, Ishii, H, Frenneaux, M, Ovize, M, Galvani, M, Atar, D, Ibanez, B, Cerisano, G, Biscaglia, S, Neil, B J, Asakura, M, Engstrom, T, Jones, D A, Dawson, D, Ferrari, R, Pinton, P & Ottani, F 2017, 'Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment Elevation Myocardial Infarction treated with percutaneous coronary intervention', Data in brief, vol. 14, pp. 197-205. https://doi.org/10.1016/j.dib.2017.07.0332352-3409PubMedCentral: PMC5537426ORCID: /0000-0003-2815-4469/work/160846753http://hdl.handle.net/2164/9274Acknowledgements Conflict of interest: Lincoff receives research support from Kai Pharmaceuticals; Gibson receives research support from Stealth pharmaceuticals; other authors do not declare conflict of interest. Funding: none. Transparency document. Supplementary material Transparency data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.dib.2017.07.033.91931909engJournal ArticleReperfusion injuryMyocardial infarctionPCICyclosporinNicorandilFollow-upR Medicine (General)R1Journal article10.1016/j.dib.2017.07.03314